Learn More
p57[Kip2] Mouse anti-Human, Unlabeled, Clone: A120-1, BD
Mouse Monoclonal Antibody
Supplier: BD Biosciences 556346
Description
Cyclin dependent kinase inhibitors (CdkIs) inhibit progression through the cell cycle by binding to cyclins, Cdks, or cyclin-Cdk complexes. CdkIs are classified into two groups based on protein structure. p57[Kip2] belongs to a group that also includes p27[Kip1] and p21 (also known as Sdi1, Cip1, Waf1 and Pic1). Members of this group have a homologous amino-terminal Cdk inhibitory domain. Members of the second group [p16 (INK4A), p15 (INK4B), p18 (INK4C), and p19 (INK4D)] contain ankyrin repeat motifs. p57[Kip2] is a potent, tight-binding inhibitor of several G1 and S phase cyclin-Cdk complexes including cyclin E-Cdk2, cyclin D2-Cdk4, and cyclin A-Cdk2. It inhibits the mitotic cyclin B1-Cdk1 complex to a lesser extent. mRNA studies suggest that p57[Kip2] expression is tissue-specific, the highest levels have been found in embryonic and adult skeletal muscle, heart, kidney, lung, eye and brain. This is in contrast to the widespread tissue expression of p27[Kip1] and p21 mRNA. The expression of p57[Kip2] to primarily terminally differentiated cells suggests that p57[Kip2] may play a specialized role in cell cycle control. Clone A120-1 reacts with human p57[Kip2]. Recombinant human p57[Kip2] was used as immunogen.
Host Species: Mouse
Clone: A120-1
Isotype: IgG1 κ
Species Reactivity: Human
Immunogen: p57[Kip2] Recombinant Human
Western Blotting

Specifications
p57[Kip2] | |
Monoclonal | |
0.5mg/mL | |
Aqueous buffered solution containing ≤0.09% sodium azide. | |
p57[Kip2] Recombinant Human | |
0.1 mg | |
Cell Biology | |
Human | |
IgG1 κ |
Western Blot | |
A120-1 | |
Unconjugated | |
Mouse | |
Affinity Purified | |
RUO | |
Primary | |
Store undiluted at 4°C |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only.